Market Overview

Benzinga's Top Upgrades, Downgrades For February 9, 2018

Share:

Top Upgrades

  • JP Morgan upgraded Air Products & Chemicals, Inc. (NYSE: APD) from Neutral to Outperform. Air Products shares fell 0.39 percent to $152.20 in pre-market trading.
  • BMO Capital upgraded Comerica Incorporated (NYSE: CMA) from Market Perform to Outperform. Comerica shares fell 4.71 percent to close at $89.18 on Thursday.
  • Raymond James upgraded T-Mobile US Inc (NASDAQ: TMUS) from Outperform to Strong Buy. T-Mobile US shares rose 0.44 percent to $59.14 in pre-market trading.
  • SunTrust Robinson Humphrey upgraded Fiserv Inc (NASDAQ: FISV) from Neutral to Buy. Fiserv rose 1.47 percent to $135.00 in pre-market trading.
  • Analysts at JP Morgan upgraded iRobot Corporation (NASDAQ: IRBT) from Underweight to Neutral. iRobot shares rose 3.60 percent to $61.95 in pre-market trading.
  • Analysts at Stephens & Co. upgraded Domtar Corp (USA) (NYSE: UFS) from Equal-Weight to Overweight. Domtar shares fell 12.61 percent to close at $42.57 on Thursday.
  • RBC Capital upgraded Viacom, Inc. (NASDAQ: VIAB) from Underperform to Sector Perform. Viacom shares fell 0.64 percent to $32.50 in pre-market trading.
  • Analysts at RBC Capital upgraded Twitter Inc (NYSE: TWTR) from Underperform to Sector Perform. Twitter shares rose 0.13 percent to $30.22 in pre-market trading.
  • Piper Jaffray upgraded Imperva Inc (NASDAQ: IMPV) from Neutral to Overweight. Imperva shares rose 2.73 percent to $43.20 in pre-market trading.
  • Bank of America upgraded American International Group Inc (NYSE: AIG) from Neutral to Buy. AIG shares rose 1.92 percent to $59.40 in pre-market trading.


Top Downgrades

  • Piper Jaffray downgraded Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) from Neutral to Underweight. Teva shares fell 1.29 percent to $18.40 in pre-market trading.
  • Raymond James downgraded Diamond Offshore Drilling Inc (NYSE: DO) from Market Perform to Underperform. Diamond Offshore Drilling shares rose 0.07 percent to $14.93 in pre-market trading.
  • Ladenburg Thalmann downgraded Southwestern Energy Company (NYSE: SWN) from Buy to Neutral. Southwestern Energy shares rose 0.82 percent to $3.67 in pre-market trading.
  • SunTrust Robinson Humphrey downgraded Lions Gate Entertainment Corporation (NYSE: LGF.B) from Buy to Hold. Lions Gate shares fell 2.11 percent to close at $29.27 on Thursday.
  • Analysts at JP Morgan downgraded 3D Systems Corporation (NYSE: DDD) from Neutral to Underweight. 3D Systems fell 1.73 percent to $9.65 in pre-market trading.
  • Stifel Nicolaus downgraded Hologic, Inc. (NASDAQ: HOLX) from Buy to Hold. Hologic shares fell 0.75 percent to $ 38.51 in pre-market trading.
  • Morgan Stanley downgraded Wynn Resorts, Limited (NASDAQ: WYNN) from Overweight to Equal-Weight. Wynn Resorts shares fell 2.23 percent to $165.50 in pre-market trading.
  • Analysts at Benchmark downgraded Expedia Inc (NASDAQ: EXPE) from Buy to Hold. Expedia shares fell 16.52 percent to $102.70 in pre-market trading.
  • DA Davidson downgraded KapStone Paper and Packaging Corp. (NYSE: KS) from Buy to Neutral. KapStone Paper shares fell 0.09 percent to close at $34.50 on Thursday.
  • BTIG Research downgraded Regeneron Pharmaceuticals Inc (NASDAQ: REGN) from Buy to Neutral. Regeneron Pharmaceuticals shares rose 0.46 percent to $324.10 in pre-market trading.


Top Initiations

  • Aegis Capital initiated coverage on RumbleON Inc (NASDAQ: RMBL) with a Buy rating. The price target for RumbleON is set to $7. RumbleON shares closed at $4.45 on Thursday.
  • Analysts at Guggenheim initiated coverage on Aclaris Therapeutics Inc (NASDAQ: ACRS) with a Buy rating. The price target for Aclaris Therapeutics is set to $53. Aclaris Therapeutics shares closed at $19.57 on Thursday.
  • Analysts at DA Davidson initiated coverage on County Bancorp Inc (NASDAQ: ICBK) with a Neutral rating. The price target for County Bancorp is set to $31. County Bancorp closed at $27.10 on Thursday.
  • Cantor Fitzgerald initiated coverage on Spero Therapeutics Inc (NASDAQ: SPRO) with an Overweight rating. The price target for Spero Therapeutics is set to $27. Spero Therapeutics shares closed at $11.97 on Thursday.
  • Guggenheim initiated coverage on Aquinox Pharmaceuticals Inc (NASDAQ: AQXP) with a Buy rating. The price target for Aquinox Pharmaceuticals is set to $26. Aquinox Pharmaceuticals shares closed at $13.40 on Thursday.

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Intraday Update Analyst Ratings

 

Related Articles (AIG + ACRS)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
GMLPReiterates10.0
JWNReiterates29.0
DSGXInitiates Coverage On43.0
ZMAssumes115.0
LOGMAssumes77.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Benzinga Pro's 6 Stocks To Watch Today

The Market In 5 Minutes: Budget Deal, MoviePass, Nvidia, And More